BiotechTube
Mironid

Mironid

Edinburgh, United Kingdom· Est.
mironid.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Mironid is a private, preclinical-stage biotech developing first-in-class small molecules for ADPKD and other rare diseases with high unmet need. Its core technology involves the allosteric modulation of long-form PDE4 enzymes, a novel mechanism intended to be disease-modifying. Led by an experienced team with backgrounds at Merck, GSK, and other biopharma firms, the company is building a pipeline and positioning itself as a future leader in PDE therapeutics. Mironid is currently pre-revenue and focused on advancing its research programs to key value inflection points.

Rare Kidney DiseasesADPKD

Technology Platform

Allosteric modulation of long-form cAMP-degrading phosphodiesterase (PDE4) enzymes for therapeutic intervention.

Opportunities

The significant unmet need in ADPKD, where current therapies have tolerability limitations, creates a large addressable market for a novel, well-tolerated disease-modifying drug.
The platform technology of PDE modulation could also be expanded to other rare kidney or fibrotic diseases, providing long-term pipeline opportunities.

Risk Factors

The novel scientific approach of allosteric PDE4 modulation is unproven in ADPKD, carrying high preclinical and clinical development risk.
The company is pre-revenue and reliant on external financing to fund expensive and lengthy clinical trials required for a chronic, progressive disease like ADPKD.

Competitive Landscape

Mironid competes in the ADPKD space against the approved drug tolvaptan and several other companies developing novel mechanisms (e.g., mTOR inhibitors, CFTR modulators, other signaling pathway inhibitors). Its differentiation lies in its specific focus on allosteric PDE4 modulation, which, if successful, could offer a unique efficacy and safety profile.

More companies in Small Molecule Drugs →More companies in United Kingdom →